Overseas Action Bodes Well for the Bulls<br />By Rev Shark<br />RealMoney.com Contributor<br />9/3/2009 8:38 AM EDT <br /><br />Our greatest weakness lies in giving up. The most certain way to succeed is always to try just one more time. <br />-- Thomas Edison<br /><br />Not a single stock on the Shanghai exchange was down overnight. All 890 stocks tacked on gains as the Shanghai exchange bounced back 4.8% after a loss of 7% on Monday. Interest rates were left unchanged in Europe, and there is positive action there as well. The good mood is spreading and early indications are that we will open strongly in the U.S. <br /><br />News flow continues to be a bit slow, but gold is up again after a big move yesterday, oil is positive and the general tone is more upbeat. <br /><br />My theme lately has been that the downside may not be quite as easy as the bears might think. Yes, we've had some deterioration in the technical picture, but the damage isn't that bad and the likelihood is that the dip-buyers have not completely given up yet. They were caught in an ugly intraday reversal on Tuesday and were unable to muster anything yesterday, but given how successful they have been for so long, it is difficult to count them out. They will need several failures before they are likely to relent. <br /><br />The market is at a tricky juncture right now. Participation is light, as many on Wall Street take vacations prior to the Labor Day holiday, and that keeps things volatile. We are in what has historically been the worst month of the year, but everyone is keenly aware of that fact. <br /><br />The most important consideration is that many market players continue to root for a pullback, not because they are bearish but because they are bullish and want better entry points. The major worry of market players for a long time has been not having enough long exposure in a market that has been unrelenting in its strength. The hope is that a pullback will finally make it easier to find good entries without having to chase things that are going straight up. <br /><br />That desire to gracefully entry this market on pullbacks is the big challenge for the bears. Until the mentality shifts from "buying opportunity" to "change in trend," the bears are going to have a hard time. We'll see today if the dip-buyers can get something going. The move in China bodes well for the bulls, and after the action of the last two days, the bears may be feeling a bit complacent and be susceptible to a short squeeze. <br /><br />Gold is going crazy again, and that is garnering attention as a market negative. Keep an eye on financials. If we hold up for the first hour or so of trading, I'll be looking for a positive trend day<br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance/SSS: DLM +11.6%, MEI +8.3%, CIEN +7.6%, OXM +6.5% (also upgraded to Buy at KeyBanc Capital Mkts), LAYN +6.3%, AEO +4.7%, COST +4.7%, GPS +3.9%, TGT +3.5%, ARO +2.8%, ZUMZ +2.6% (also upgraded to Buy at MKM Partners), JTX +2.1%, SAI +1.8%... Select financials rebounding: FNM +13.1%, FRE +10.4%, MBI +9.1%, IRE +8.3%, PMI +8.1%, ABK +6.0%, AIG +4.7%, ING +4.4%, UBS +4.3%, AIB +4.3%, DB +4.0% (denies it is bidding for Postbank shares - Reuters.com), CS +3.0%, C +2.8%, BAC +2.0%, HBC +1.9%, MS +1.8%, JPM +1.1%, GS +1.0%... Select metals/mining names seeing early strength: SWC +5.2%, HMY +4.4%, MT +3.9%, BBL +3.5%, RTP +3.1%, BHP +2.6%... Select China related names showing strength following +4.8% gain in Shanghai: LFC +2.1%, PTR +2.0%, BIDU +1.8%... Select aluminum names showing strength following reports that Alcoa raised world aluminum forecast on China demand: CENX +5.9%, ACH +4.9%, AA +2.9%... Other news: BNVI +42.9% (to Present positive results from phase 2 trial of menerba for vasomotor symptoms to the international community), CRIS +37.1% (announces GDC-0449 Phase I clinical data published in New England Journal of Medicine), ALTH +21.0% (FDA panel backs Allos Therapeutics' cancer drug - AP), DHT +7.5% (rebounding from yesterday's 20% drop), NOK +4.5% (still checking), SHPGY +1.3% (announces FDA approval of once-daily INTUNIV extended release tablets for the treatment of ADHD in children and adolescents aged 6 to 17)... Analyst comments: GNW +4.5% (initiated with an Outperform at Northland Securities), TC +4.0% (upgraded to Sector Perform at CIBC Wrld Mkts), CCL +3.6% (raised to $34 at Credit Suisse as volume growth remains encouraging), DHR +2.5% (upgraded to Outperform at FBR Capital), BEN +2.4% (upgraded to Outperform at Keefe Bruyette), SI +2.4% (upgraded to Outperform at Bernstein), APC +2.1% (upgraded to Outperform at FBR Capital), AAPL +1.2% (initiated with an Outperform at William Blair).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance/SSS: INWK -13.4%, FDO -8.2%, HOV -5.4% (downgraded to Underperform at Credit Suisse), UTIW -5.4%, MATK -5.0%, ABM -4.4% (light volume), ANF -4.0%, JCP -1.6%... M&A news: JAVA -2.3% (EU to probe Oracle-Sun deal - WSJ)... Other news: CHNG -2.6% (priced a ~5.725 mln share common stock offering at $8.75/share), CRXL -2.6% (still checking), ENDP -2.4% (FDA has extended its review period for its long-acting testosterone undecanoate injection)... Analyst comments: DE -2.1% (downgraded to Underweight at JPMorgan).